Silk Road Medical Inc
NASDAQ:SILK 3:59:47 PM EDT
| Market Cap (Intraday) | 1.91B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $59.62 |
| 50-Day MA | $59.62 |
| 200-Day MA | $53.05 |
Silk Road Medical Inc Stock, NASDAQ:SILK
1213 INNSBRUCK DR., SUNNYVALE, CA 94089-2918
United States of America
Phone: 6505669060
Number of Employees:
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.